Please assess the completion status of the following clinical trial:

Trial Title: Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-50~* Patients who are candidate for abdominal myomectomy~Exclusion Criteria:~* History of previous myomectomy.~* Suspected malignancy~* Patients with preoperative anemia~* Patients using hormonal treatments before the surgery.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Oxytocin infusion (Type: EXPERIMENTAL): Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.
- Placebo (Type: PLACEBO_COMPARATOR): Patients will receive pure normal saline infusion at the same rate and volume just before the surgery after the induction of general anesthesia.

Based on this trial design, predict the completion outcome and termination type (if applicable).